Weber, M. S. (2015). Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? Neurol Neuroimmunol Neuroinflamm.
Chicago-стиль цитированияWeber, Martin S. "Is Intrathecal Anti-CD20 an Option to Target Compartmentalized CNS Inflammation in Progressive MS?" Neurol Neuroimmunol Neuroinflamm 2015.
MLA-цитированиеWeber, Martin S. "Is Intrathecal Anti-CD20 an Option to Target Compartmentalized CNS Inflammation in Progressive MS?" Neurol Neuroimmunol Neuroinflamm 2015.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.